Literature DB >> 17520449

Preparation of azithromycin nanosuspensions by high pressure homogenization and its physicochemical characteristics studies.

Dianrui Zhang1, Tianwei Tan, Lei Gao, Wenfa Zhao, Peng Wang.   

Abstract

The azalide azithromycin was proved to be clinically effective against Gram-positive and Gram-negative bacteria. But the low bioavailability caused by its poor solubility and gastrointestinal response limited its application in clinic. With the purpose of increasing its saturation solubility and dissolution velocity, azithromycin was produced as nanosuspensions by high pressure homogenization. Nanosuspensions could increase the drug-loading and reduce the administration dosage, thus the gastrointestinal response could be minimized. In order to enhance the stability of the nanosuspensions, we got the freeze-dried powder by lyophilization. After dispersed in distilled water, the nanoparticles had a bulk population of about 400 nm and a spherical figure (watched by transmission electron microscopy). The analysis of differential scanning calorimetry and powder X-ray diffraction demonstrated that the crystal state of azithromycin had changed. In vitro release studies showed that the dissolution rate of nanosuspension, compared with micronized powder, had been obviously increased.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17520449     DOI: 10.1080/03639040600975147

Source DB:  PubMed          Journal:  Drug Dev Ind Pharm        ISSN: 0363-9045            Impact factor:   3.225


  14 in total

1.  Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation.

Authors:  Peng Quan; Dengning Xia; Hongze Piao; Hongyu Piao; Kai Shi; Yinnong Jia; Fude Cui
Journal:  AAPS PharmSciTech       Date:  2011-09-03       Impact factor: 3.246

Review 2.  Preclinical formulations: insight, strategies, and practical considerations.

Authors:  Sanket M Shah; Ankitkumar S Jain; Ritu Kaushik; Mangal S Nagarsenker; Maneesh J Nerurkar
Journal:  AAPS PharmSciTech       Date:  2014-06-12       Impact factor: 3.246

3.  The role of particle size of glyburide crystals in improving its oral absorption.

Authors:  Wenqian Yang; Yongjun Wang; Qiang Fu; Zhibin Guo; Bingjun Sun; Wen Liu; Yaxuan Liu; Simeng Mu; Mengran Guo; Jingru Li; Xiaohui Pu; Zhonggui He
Journal:  Drug Deliv Transl Res       Date:  2017-06       Impact factor: 4.617

4.  Formulation, biological and pharmacokinetic studies of sucrose ester-stabilized nanosuspensions of oleanolic Acid.

Authors:  Wenji Li; Surajit Das; Ka-yun Ng; Paul W S Heng
Journal:  Pharm Res       Date:  2011-04-09       Impact factor: 4.200

Review 5.  Application of drug nanocrystal technologies on oral drug delivery of poorly soluble drugs.

Authors:  Lei Gao; Guiyang Liu; Jianli Ma; Xiaoqing Wang; Liang Zhou; Xiang Li; Fang Wang
Journal:  Pharm Res       Date:  2012-10-17       Impact factor: 4.200

6.  Azithromycin-loaded linolenic acid-modified methoxy poly(ethylene glycol) micelles for bacterial infection treatment.

Authors:  Yi Wen; Zhimei Song; Hongmei Xu; Sijia Feng; Li Zhu; Fangfang Teng; Runliang Feng
Journal:  Drug Deliv Transl Res       Date:  2021-03-14       Impact factor: 4.617

7.  Berberine nanosuspension enhances hypoglycemic efficacy on streptozotocin induced diabetic C57BL/6 mice.

Authors:  Zhiping Wang; Junbiao Wu; Qun Zhou; Yifei Wang; Tongsheng Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-03-17       Impact factor: 2.629

Review 8.  High drug-loading nanomedicines: progress, current status, and prospects.

Authors:  Shihong Shen; Youshen Wu; Yongchun Liu; Daocheng Wu
Journal:  Int J Nanomedicine       Date:  2017-05-31

9.  Preparation, characterization and pharmacokinetics of cyadox nanosuspension.

Authors:  Adeel Sattar; Dongmei Chen; Lishun Jiang; Yuanhu Pan; Yanfei Tao; Lingli Huang; Zhenli Liu; Shuyu Xie; Zonghui Yuan
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

10.  Nanotechnology-based drug delivery systems.

Authors:  Sarabjeet Singh Suri; Hicham Fenniri; Baljit Singh
Journal:  J Occup Med Toxicol       Date:  2007-12-01       Impact factor: 2.646

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.